-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Regulus Therapeutics Inc. quarterly/annual Interest Expense history and growth rate from 2010 to 2023.
- Regulus Therapeutics Inc. Interest Expense for the quarter ending March 31, 2024 was $81K, a 56.2% decline year-over-year.
- Regulus Therapeutics Inc. Interest Expense for the twelve months ending March 31, 2024 was $500K, a 30.4% decline year-over-year.
- Regulus Therapeutics Inc. annual Interest Expense for 2023 was $604K, a 12.2% decline from 2022.
- Regulus Therapeutics Inc. annual Interest Expense for 2022 was $688K, a 19.5% decline from 2021.
- Regulus Therapeutics Inc. annual Interest Expense for 2021 was $855K, a 52.7% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)